Synthesis, Conformation of 3′-(Tetrazole-2″-yl)-3′-deoxythymidine and its 5″-Derivatives. Substrate Properties of 3′-(Tetrazole-2″-yl)-3′-deoxythymidine 5′-Triphosphate
摘要:
5'-O-Benzoyl-3'-(tetrazole-2 ''-yl)-3'-deoxythymidine and its 5 ''-substituted derivatives were obtained by the reaction of 5'-O-benzoyl-2,3'-anhydrothymidine with triethylammonium salts of either tetrazole or 5-substituted tetrazoles. Debenzoylation of these compounds yielded 3'-(tetrazole-2 ''-yl)-3'-deoxythymidine and its 5 ''-derivatives. Structures of two of them were confirmed by X-ray analysis. Both 3'-(tetrazole-2 ''-yl)-3'-deoxythymidine and 3'-(5 ''-methyltetrazole-2 ''-yl)-3'-deoxythymidine have anti-conformation with respect to the glycosidic bond, and 2'-endo-3'-exo-conformation of the sugar residue with gauche(+) orientation relative to the C4'-C5' bond. 3'-(Tetrazole-2 ''-yl)-3'-deoxythymidine 5'-triphosphate exhibited poor termination substrate properties towards avian myeloblastosis virus reverse transcriptase and did not serve as a substrate for other employed DNA polymerases.
Malin, A. A.; Ostrovskii, V. A.; Yas'ko, M. V., Russian Journal of Organic Chemistry, 1995, vol. 31, # 4, p. 581 - 582
作者:Malin, A. A.、Ostrovskii, V. A.、Yas'ko, M. V.、Kraevskii, A. A.
DOI:——
日期:——
Ostrovskii, V. A.; Ivanova, N. V.; Malin, A. A., Russian Journal of Organic Chemistry, 1993, vol. 29, # 11.2, p. 1947 - 1948
作者:Ostrovskii, V. A.、Ivanova, N. V.、Malin, A. A.、Shcherbinin, M. B.、Poplavskii, V. S.、Studentsov, E. P.
DOI:——
日期:——
METALLOENZYME INHIBITOR COMPOUNDS
申请人:Hoekstra William J.
公开号:US20120309800A1
公开(公告)日:2012-12-06
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
US8987315B2
申请人:——
公开号:US8987315B2
公开(公告)日:2015-03-24
[EN] METALLOENZYME INHIBITOR COMPOUNDS<br/>[FR] COMPOSÉS INHIBITEURS DE MÉTALLO-ENZYME
申请人:VIAMET PHARMACEUTICALS INC
公开号:WO2011082245A2
公开(公告)日:2011-07-07
The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.